Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Mirada Medical 's latest XD3 multi-modality image fusion analysis package  (Oncology Fusion)  is now available as a fully integrated option  within Vitrea Enterprise Suite (VES)  from Vital Images.

Mirada Medical Limited, the fast growing international company focused on advanced oncology imaging, announced that  its latest XD3 multi-modality image fusion analysis package  (Oncology Fusion)  is now available as a fully integrated option  within Vitrea Enterprise Suite (VES)  from Vital Images. The  integrated solution is designed to increase productivity and workflow efficiency.

Oncology Fusion enables the visualization, quantification and tracking of tumors with rigid and  deformable fusion algorithms for CT , MR , PET and SPECT. Integrated within VES,  Vital  Images’ comprehensive advanced visualization and image distribution solution,  users are  able to access Oncology Fusion directly from their Vital Images solution, which also enables anywhere access via a Web browser. Oncology Fusion is designed to deliver improved levels of productivity  for radiologists and other users of medical imaging who want to access the most advanced applications and workflows on a single unified platform.

Oncology Fusion provides  quantifications  such as SUV measurements and access to standard disease response protocols such as RECIST for CT and PERCIST for PET and PETCT. The Mirada software supports comparison of two or more PET/CTs and also allows
users to fuse MRI with PET, SPECT or CT.  Mirada’s Oncology Fusion application also incorporates the latest versions of Mirada ’s leading deformable image registration algorithms, which allow any combination of image modalities  to be registered non-rigidly allowing for corrections to be made where  patient positioning is inconsistent, or patient anatomy has changed over time.

Commenting on  the new product release, Hugh Bettesworth, CEO of Mirada Medical, said: “It is central to Mirada’s philosophy that we make the advanced technologies available to the widest range of clinical users. By tightly integrating our Oncology Fusion application with the Vital Enterprise Server, users of this system can experience what we believe are the leading multi-modality workflows available anywhere, and in a way that can significantly boost productivity allowing more scans to be accurately analysed and reported.”

“Offering Oncology Fusion within VES supports our commitment to  supporting multiple modalities  and  comprehensive clinical functionality to our customers,”  commented Erkan Akyuz, executive vice president of product strategy and development at Vital Images.

Source: Mirada Medical